Page last updated: 2024-11-05

n-methylolacrylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylolacrylamide: bifunctional monomer possessing both vinyl & hydroxymethyl groups; used in adhesives, binders, surface coatings & resins; toxicity equals that of acrylamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13543
CHEMBL ID1892361
CHEBI ID82492
SCHEMBL ID25806
MeSH IDM0182331

Synonyms (55)

Synonym
ai3-25447
n-hydroxymethyl acrylamide
n-(hydroxymethyl)-2-propenamide
ccris 2380
nsc 553
hsdb 4361
n-methyloacrylamide
einecs 213-103-2
nci-c60333
hydroxymethylacrylamide
brn 0506646
inchi=1/c4h7no2/c1-2-4(7)5-3-6/h2,6h,1,3h2,(h,5,7
2-propenamide, n-(hydroxymethyl)-
acrylamide, n-(hydroxymethyl)-
n-methanolacrylamide
monomethylolacrylamide
yuramin t 80
uramine t 80
nsc553
n-methylolacrylamide
n-(hydroxymethyl)acrylamide
924-42-5
nsc-553
methylolacrylamide
NCGC00163845-01
NCGC00163845-02
n-(hydroxymethyl)prop-2-enamide
M0574
A844235
C19456
ec 213-103-2
w8w68jl80q ,
unii-w8w68jl80q
n-methylol acrylamide
AKOS006222324
n-mam
methylolacrylamide, n-
n-(hydroxymethyl)acrylamide [hsdb]
rocagil bt
n-methylolacrylamide [iarc]
chebi:82492 ,
CHEMBL1892361
SCHEMBL25806
n-(hydroxymethyl) acrylamide
W-100289
nm-amd
DTXSID3020885
mfcd00004597
FT-0720637
BS-17859
Q26840808
E78933
n-(hydroxymethyl)acrylamide 100 microg/ml in acetonitrile
CS-W013710
EN300-7474805

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Landing footspread was also increased in dosed rats compared to controls."( Neurotoxicity and carcinogenicity of N-methylolacrylamide in F344 rats and B6C3F1 mice.
Bucher, JR; Eustis, SL; Haseman, JK; Huff, J; Peters, A; Toft, JD, 1990
)
0.55
" The last litter was reared and dosed after weaning until mating at 74 +/- 10 days of age with the same level of compound given to the parents Neurotoxicity was assessed at several times in both generations by measuring forelimb and hindlimb grip strength."( The reproductive and neural toxicities of acrylamide and three analogues in Swiss mice, evaluated using the continuous breeding protocol.
Chapin, RE; Collins, BJ; Fail, PA; George, JD; Grizzle, TB; Harry, GJ; Heindel, JJ; Teague, J, 1995
)
0.29
" An additional mouse MN test was conducted using a 31-day treatment period to better match the dosing regimen used in the breeding study; the results were negative."( Mouse bone marrow micronucleus test results do not predict the germ cell mutagenicity of N-hydroxymethylacrylamide in the mouse dominant lethal assay.
Bishop, JB; Black, SL; Burka, LT; Hughes, LA; Mathews, JM; McFee, AF; Witt, KL, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
secondary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a primary amine; formula RC(=O)NHR(1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency39.81070.000817.505159.3239AID588544
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.07510.010039.53711,122.0200AID588545; AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency501.18700.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (18.75)18.2507
2000's9 (28.13)29.6817
2010's16 (50.00)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.90 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index38.53 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]